Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cholangiocarcinoma × Exercise × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 28 Colorectal Neoplasms 24 Colonic Neoplasms 15 Neoplasms 11 Pancreatic Neoplasms 10 Rectal Neoplasms 9 Breast Neoplasms 9 Stomach Neoplasms 6 Esophageal Neoplasms 5 Prostatic Neoplasms 4 Liver Neoplasms 3 Postoperative Complications 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Weight Loss 1 Urinary Incontinence 1 Thyroid Neoplasms 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Risk Reduction Behavior 1 Psychological Well-Being 1 Peripheral Nervous System Diseases 1 Patient Compliance 1 Pancreas Adenocarcinoma 1 Obesity 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma 1 Malabsorption Syndromes 1

Interventions

Gemcitabine 109 Cisplatin 74 Oxaliplatin 45 pembrolizumab 34 Fluorouracil 32 Capecitabine 31 lenvatinib 26 durvalumab 26 Leucovorin 26 Magnetic Resonance Spectroscopy 14 Irinotecan 13 Drug Therapy 13 Nivolumab 12 Biopsy 12 Albumin-Bound Paclitaxel 12 Specimen Handling 11 Radiofrequency Ablation 11 130-nm albumin-bound paclitaxel 11 tislelizumab 10 pemigatinib 10 apatinib 10 Taxes 10 Radiotherapy 10 Floxuridine 10 Bevacizumab 9 Photochemotherapy 8 Liver Transplantation 8 Folfox protocol 8 Cholangiopancreatography, Endoscopic Retrograde 8 Carboplatin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02162914 2020-07-31

REACHIN

Erasme University Hospital

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡